DSAC · Daedalus Special Acquisition Corp.
$10.18
+0.01 (+0.10%)
At close · Jul 28
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the foregoing, these factors, among others, raise substantial doubt about the Company's ability to continue as a going concern one year from the date these financial statements are issued.”View the 10-Q filed May 12, 2026
Market Cap
$346.31M
Shares
34.02M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.18
Open$10.17
Day$10.16–10.18
52W$9.90–10.47
Avg vol 30d80K
Short int16K · 0.0% float · 1.0d
Short vol1%
Last earningsSep 30, 2025
DataJan 2026–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Neutral
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+1%
above
RSI (14)
72
overbought
MACD trend
Negative
52-week position
49%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+2%
trailing
Relative strength
−5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
3 of 53 funds reported for Jun 30 · net -75.0K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.05% of float · ▲ +15.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
53 holders — 13F breadth
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
3%
annualized · 1-yr
Max drawdown
−1%
past year
ATR
0.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Sep 30, 2025
Total revenue
· full year 2025
Initiated
$95M – $96M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+1%
Bullish
RSI (14)
72
Bearish
MACD trend
Negative
Bearish
52-week position
49%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
3 of 53 funds reported for Jun 30 · net -75.0K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.05% of float · ▲ +15.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
53 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $10
Now $10 · 49%
52-wk high $10
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DSAC
this stock
Daedalus Special Acquisition Corp.
|
$346.31M | — | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | +0.0% | — | 100.2 | — |
|
XXI
Twenty One Capital, Inc.
|
$2.87B | -49.8% | — | — | 0.7% |
|
CCXI
Churchill Capital Corp XI
|
$764.20M | — | — | — | 1.8% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$643.69M | +2.1% | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DSAC | +0.2% | +0.8% | +2.0% | +0.9% | — |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +1.2% | +0.8% | -5.4% | +1.7% | — |
Key facts
CIK
2082149
CUSIP
G2616C108
13F (30d)
2 filings
2 filers